Cannabis Category Performance Comparisons: An Update

The 5 categories in the cannabis sector perform quite differently from each other and below is a summary of how each category has performed month-to-date (MTD) in descending order and year-to-date (YTD):

  1. The American Cannabis MSOs Index: down 4.4% MTD; down 8.2% YTD 
    • The Index consists of the 12 largest American Multi-State Operators, namely, Acreage (ACRDF/ACRHF); Ascend Wellness (AAWH); Ayr Wellness (AYRWF); Columbia Care (CCHWF); Cresco (CRLBF); Curaleaf (CURLF); Green Thumb (GTBIF);  Jushi (JUSHF); Planet 13 (PLNHF); TerrAscend (TRSSF); Trulieve (TCNNF) and Verano  (VRNOF).
  2. The Conservative Pot Stocks Index: down 4.9% MTD; down 6.1% YTD
    • The Index consists of 6 tobacco, beer, and liquor companies that have invested heavily in the cannabis industry, namely, Altria Group (MO); Anheuser-Busch  (BUD); British American Tobacco (BTI); Constellation Brands (STZ);  Imperial Brands (IMBBY) and Molson Coors Brewing Company (TAP).
    • The constituent stocks all pay dividends with yields ranging from just 0.9% for Anheuser Busch to 8.4% for Altria and average out at 3.1%.
  3. The Canadian Cannabis LPs Index: down 9.4% MTD; down 13.3% YTD
    • The Index consists of the 5 largest Canadian Licensed Producers, namely: Aurora (ACB); Canopy Growth (CGC); Cronos (CRON); Organigram (OGI), and Tilray (TLRY).
  4. The Ancillary Pot Stock Indexdown 12.2% MTD; up 0.4% YTD
    • The Index consists of the 7 largest companies providing goods and services to the cannabis sector, namely, AFC Gamma  (AFCG); Forian (FORA);  Hydrofarm (HYFM); GrowGeneration (GRWG); Innovative Industrial Properties (IIPR);  Scotts Miracle-Gro Company (SMG) and Turning Point Brands (TPB).
  5. The Psychedelic Drug Stocks Indexdown 14.3% MTD; down 10.2% YTD
    • The Index consists of 7 psychedelic compound-based and marijuana (THC) drug companies in the clinical stages of research and development of treatments for a wide variety of mental illnesses, namely Cybin (CYBN); Atai (ATAI); Seelos (SEEL), Compass Pathway (CMPS); Mind Medicine (MNMD), GH Resources (GHRS) and  Incannex Healthcare (IXHL), the newest addition to the list.

In summary, the 5 cannabis/cannabis-related company stock category performances ranged from: -4.4% to -14.3% YTD.

More By This Author:

An Update On The Performance Of The 7 Largest Psychedelic Stocks
The "Multi-Bagger" Portfolio: An Update
The "Rags-To-Riches" Portfolio: An Update

Disclosure: None

Visit and register to receive our free Market Intelligence Report newsletter (sample  more

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.